Is Eris Lifesciences Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Eris Lifesciences Limited pays dividends. Last time was Sunday 4th of September 2022 where the investors holding the stock on Thursday 11th of August 2022 were paid INR7.35 per share. Over the last 4 times between 2020 and 2022, Eris Lifesciences Limited has paid INR21.73 with an average of INR5.43 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Eris Lifesciences Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR370.20, you would have made a profit of INR1 078.25 per share or 291.26%
Yes, the average daily trading liquidity for Eris Lifesciences Limited is INR241 968 thousand. You should therefore be able to get in and out of your positions relatively fast.
Eris Lifesciences Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.09, the company's ability to pay off the debt is limited. Eris Lifesciences Limited has a good net profit margin of 19.65% and should have high tolerances against inflation.
We have calculated the inflation risk for Eris Lifesciences Limited to be medium [0.55 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.